India Cancels Novartis Vymada Patent, Opens Market to Generics
A major update has been released by the Indian Patent Office (IPO) that could significantly reshape the Indian pharmaceutical market. Novartis Vymada Patent Revoked in India. The IPO has revoked/canceled the patent held by Novartis, the Swiss multinational pharmaceutical giant based in Basel, Switzerland, on its blockbuster cardiac drug Vymada (also known globally as Entresto). […]
USAA Patent Dispute Reaches Supreme Court as Battle Over Mobile Deposit Technology Intensifies
A big patent fight in the United States is making headlines as USAA’s long battle with major banks over mobile check deposit technology reaches the Supreme Court. The key question is whether USAA’s patents represent real innovation or simply cover a basic idea that should not be protected. The outcome of the USAA patent dispute […]
Patent Eligibility Across Jurisdictions: What You Need to Know
Patenting is very complex and involves multiple stages, and the complexity increases when we try to file a patent in multiple regions or countries. In 2024–25, India granted around 26,000 patents out of 78,000 applications, meaning nearly 67% were rejected or not granted, mainly due to non-eligibility, lack of novelty, or poor documentation. To deal […]